ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
85499819
Registration Number
4378430
Word Mark
ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY
Status
710 - Cancelled - Section 8
Status Date
2020-03-13
Filing Date
2011-12-20
Registration Number
4378430
Registration Date
2013-08-06
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010701, 241501, 241510, 261101 - Globes with outlines of continents. Arrows forming a circle or an arc of a circle. More than one arrow. Rectangles as carriers or rectangles as single or multiple line borders.
Published for Opposition Date
2013-05-21
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
LEVINE, HOWARD B
Statements
Indication of Colors claimed
The color(s) blue, red, black an white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY"
Description of Mark
The mark consists of the stylized wording "ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY" in white with a black globe with white continents and two blue arrows and one red arrow, all on a blue rectangle.
Goods and Services
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use
Goods and Services
Medical and scientific research, namely, conducting of clinical studies and trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials
Pseudo Mark
ROAD MAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-03-13
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-03-13
Primary Code
042
Correspondences
Name
Rebeccah Gan
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
0000-00-00 | Japan | False | |
0000-00-00 | Japan | False | |
Japan | False | ||
Japan | False |
Trademark Events
Event Date | Event Description |
2011-12-23 | NEW APPLICATION ENTERED IN TRAM |
2012-01-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2012-01-04 | NOTICE OF DESIGN SEARCH CODE MAILED |
2012-01-20 | ASSIGNED TO EXAMINER |
2012-01-23 | NON-FINAL ACTION WRITTEN |
2012-01-24 | NON-FINAL ACTION MAILED |
2012-06-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2012-07-03 | ASSIGNED TO LIE |
2012-07-06 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2012-07-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2012-07-27 | SUSPENSION LETTER WRITTEN |
2012-07-27 | LETTER OF SUSPENSION MAILED |
2013-01-30 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2013-02-21 | SUSPENSION INQUIRY WRITTEN |
2013-02-21 | INQUIRY AS TO SUSPENSION MAILED |
2013-03-27 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
2013-03-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2013-03-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2013-04-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2013-04-17 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2013-05-01 | NOTICE OF PUBLICATION |
2013-05-21 | PUBLISHED FOR OPPOSITION |
2013-08-06 | REGISTERED-PRINCIPAL REGISTER |
2015-09-04 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2015-09-04 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2018-08-06 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2020-03-13 | CANCELLED SEC. 8 (6-YR) |